REVENUES

6 Months Ended

Jun. 30, 2024

REVENUES

REVENUES

NOTE 4 – REVENUES

The following table summarizes the Company’s disaggregation of revenues:

	Six Months Ended June 30,				Three Months Ended June 30,
(U.S. dollars in thousands)	2024		2023		2024		2023
Pfizer	$	8,001	$	5,668	$	6,874	$	3,402
Brazil	$	7,266	$	2,800	$	4,716	$	—
Chiesi	$	1,714	$	11,673	$	1,714	$	11,673
Total revenues from selling goods	$	16,981	$	20,141	$	13,304	$	15,075
Revenues from license and R&D services	$	241	$	24,522	$	170	$	20,000